May 26, 2022 | Biotech, Frontpage, Impact, News, Translation
New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease. More importantly, NU-9 has an...
Feb 28, 2022 | Biotech, Frontpage, News
Growing up in Germany as a young person with allergies, Ulrich Thienel, MD, PhD, Chief Executive Officer of ReAlta Life Sciences and member of Chemistry of Life Processes Institute’s (CLP) Executive Advisory Board, spent a lot of time in the doctor’s office. That...
Jan 27, 2022 | Biotech, Frontpage, News, Translation
Northwestern University scientist have discovered families of proteins in the body that could potentially predict which patients may reject a new organ transplant, helping inform decisions about care. The advancement marks the beginning of a new era for more precise...
Jan 26, 2022 | Biotech, News, Translation
Chemistry of Life Processes Institute member Guillermo A. Ameer, Daniel Hale Williams Professor of Biomedical Engineering at the McCormick School of Engineering and Surgery at the Feinberg School of Medicine, has been given the the 2022 Technology Innovation and...
Jan 19, 2022 | Biotech, Frontpage, Impact, News, Translation
Eight years ago, an international team of researchers proposed that the term “proteoform” be adopted to describe the vast number of forms of protein products from our genes—including changes due to genetic variations, alternative RNA splicing, and post-translational...
Sep 21, 2021 | Biotech, Frontpage, News, Translation
Claudia Ctortecka was both sceptical and intrigued when her thesis adviser told her in 2018 about a new method that uses mass spectrometry to analyse the protein contents of individual cells. When he said he was looking for someone to pursue this single-cell...
